Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,231.60 -75.60 -0.49%
S&P 500 1,645.60 -9.75 -0.59%
Nasdaq 3,448.68 -14.62 -0.42%
Ticker Volume Price Price Delta
STOXX 50 2,774.15 -60.86 -2.15%
FTSE 100 6,683.73 -156.54 -2.29%
DAX 8,331.88 -199.01 -2.33%
Ticker Volume Price Price Delta
Nikkei 14,484.00 -1,143.28 -7.32%
Hang Seng 22,669.70 -591.40 -2.54%
S&P/ASX 200 5,062.45 -102.92 -1.99%
  • Exchange: NASDAQ CM
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

OncoGenex Pharmaceutical Inc

+ Add to Watchlist

OGXI:US

10.4000 USD 0.2300 2.26%

As of 10:25:08 ET on 05/23/2013.

Company Profile for OncoGenex Pharmaceutical Inc (OGXI)

OncoGenex Pharmaceutical Inc. is a biopharmaceutical company that develops and commercializes new cancer therapies that address treatment resistance in cancer patients.

Contact Information

OncoGenex Pharmaceutical Inc

1522 217th Place SE
Suite 100
Bothell, WA 98021
United States
Phone: 1-425-487-9500
Fax: 1-425-489-0626

Key Executives for OncoGenex Pharmaceutical Inc (OGXI)

Scott CormackPresident/CEOCindy A JacobsExec VP/Chief Medical Ofcr

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil